Your browser doesn't support javascript.
loading
VRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study.
Nørgaard, Jakob Nordberg; Moore, Kari Lenita Falck; Slørdahl, Tobias S; Vik, Anders; Tvedt, Tor Henrik Anderson; Schjesvold, Fredrik.
Afiliação
  • Nørgaard JN; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway. jaknoe@ous-hf.no.
  • Moore KLF; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. jaknoe@ous-hf.no.
  • Slørdahl TS; KG Jebsen Center for B cell malignancies, University of Oslo, Oslo, Norway. jaknoe@ous-hf.no.
  • Vik A; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway.
  • Tvedt THA; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Schjesvold F; KG Jebsen Center for B cell malignancies, University of Oslo, Oslo, Norway.
Blood Cancer J ; 14(1): 60, 2024 Apr 09.
Article em En | MEDLINE | ID: mdl-38594252

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mieloma Múltiplo Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mieloma Múltiplo Idioma: En Ano de publicação: 2024 Tipo de documento: Article